23andMe, Genentech to analyze 3,000 Parkinson's genomes

January 6, 2015 5:00 PM

17 0

(Reuters) - Privately held 23andMe Inc and Genentech said on Tuesday they will work together to generate whole genome sequencing data for about 3,000 people with Parkinson's disease, in order to identify new therapeutic targets for treating the degenerative neurological condition.

23andMe, co-founded by Anne Wojcicki, the wife of Google co-founder Sergey Brin, will contribute the genome sequencing and data from its Parkinson's disease community. Genentech, a unit of Roche Holding AG, will work to identify potential therapeutics based on that information.

Read more

To category page